702 related articles for article (PubMed ID: 6331663)
1. Presence of transforming growth factors in human breast cancer cells.
Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
[TBL] [Abstract][Full Text] [Related]
2. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
3. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
Salomon DS; Zwiebel JA; Noda M; Bassin RH
J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factors in solid human malignant neoplasms.
Nickell KA; Halper J; Moses HL
Cancer Res; 1983 May; 43(5):1966-71. PubMed ID: 6299535
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
6. Anchorage-independent growth-conferring factor production by rat mammary tumor cells.
Zwiebel JA; Davis MR; Kohn E; Salomon DS; Kidwell WR
Cancer Res; 1982 Dec; 42(12):5117-25. PubMed ID: 6291748
[TBL] [Abstract][Full Text] [Related]
7. Effect of phorbol esters on the activity of purified transforming growth factors.
Kraft AS
Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
[TBL] [Abstract][Full Text] [Related]
8. Production of transforming growth factors by human colon cancer lines.
Coffey RJ; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
[TBL] [Abstract][Full Text] [Related]
9. Partial purification of transforming growth factors from human milk.
Zwiebel JA; Bano M; Nexo E; Salomon DS; Kidwell WR
Cancer Res; 1986 Feb; 46(2):933-9. PubMed ID: 3000589
[TBL] [Abstract][Full Text] [Related]
10. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
11. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
[TBL] [Abstract][Full Text] [Related]
12. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
13. Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T.
Valverius EM; Ciardiello F; Heldin NE; Blondel B; Merlo G; Smith G; Stampfer MR; Lippman ME; Dickson RB; Salomon DS
J Cell Physiol; 1990 Nov; 145(2):207-16. PubMed ID: 2174061
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor production by chemically transformed cells.
Moses HL; Branum EL; Proper JA; Robinson RA
Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor.
van Zoelen EJ; van Oostwaard TM; van der Saag PT; de Laat SW
J Cell Physiol; 1985 May; 123(2):151-60. PubMed ID: 2984216
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide.
Eppstein DA; Marsh YV; Schryver BB; Bertics PJ
J Cell Physiol; 1989 Nov; 141(2):420-30. PubMed ID: 2530243
[TBL] [Abstract][Full Text] [Related]
17. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
Kanno H; Shinonaga M; Kuwabara T; Umeda M
No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
[TBL] [Abstract][Full Text] [Related]
18. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
[TBL] [Abstract][Full Text] [Related]
19. Epithelial tissue-derived growth factor-like polypeptides.
Halper J; Moses HL
Cancer Res; 1983 May; 43(5):1972-9. PubMed ID: 6572559
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]